Principia Wealth Advisory’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.61K Buy
158
+11
+7% +$562 ﹤0.01% 293
2026
Q2
$7.71K Sell
147
-2
-1% -$106 ﹤0.01% 285
2026
Q1
$8.22K Buy
149
+40
+37% +$2.17K ﹤0.01% 230
2025
Q4
$5.34K Hold
109
– – ﹤0.01% 264
2025
Q3
$4.7K Buy
109
+72
+195% +$2.81K ﹤0.01% 278
2025
Q2
$1.42K Buy
+37
New +$1.41K ﹤0.01% 474

Other funds holding GSK

Principia Wealth Advisory's GSK Position: Q3 2026 in Review

Principia Wealth Advisory increased its GSK (GSK) stake by 7.5% in Q3 2026, buying an estimated $562 and bringing the position to 158 shares worth $7.61K. The position accounts for ﹤0.01% of the portfolio, ranked #293.

Principia Wealth Advisory first reported a position in GSK in Q2 2025 and has held it in 6 quarters since. The position peaked at $8.22K in Q1 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Principia Wealth Advisory held 158 shares of GSK worth $7.61K as of Q3 2026.
  • Principia Wealth Advisory bought 11 GSK shares in Q3 2026, an estimated $562.
  • GSK made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q3 2026, its #293 holding.
  • Principia Wealth Advisory first reported a position in GSK in Q2 2025 and has held it in 6 quarters since.
  • Principia Wealth Advisory's GSK position peaked at $8.22K in Q1 2026.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Principia Wealth Advisory's 13F filing for Q3 2026, filed 12 Nov 2026.